Ovarian Cancer Trial, Recruiting NCT07387263 Sponsor: Unity Health Toronto Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT07387263
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are having genetic testing done (related to an inherited cancer risk) that was ordered by your cancer doctor, not through a genetics clinic referral
  • You are 18 years old or older
  • You can speak and read English

Who may not be able to join:

  • Your cancer genetic testing was arranged through a referral to a genetics clinic
  • You do not speak or read English
  • You are under 18 years of age
  • You have been assessed as having difficulty making consistent or fully informed decisions (confirm with trial site)
  • You do not have access to the internet or an electronic device such as a phone, tablet, or computer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Unity Health Toronto
Registry
ClinicalTrials.gov
Start date
30 April 2026
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Test Specific Distress - Multi-Dimensional Impact of Cancer Risk Assessment (MICRA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov